Adaptive Biotechnologies

ADPT58

Penny Stock

$4.49arrow_drop_up2.97%$0.12

Penny Stock

ADPT58

$4.49

arrow_drop_up2.97%$0.12

Penny Stock

Performance History

Key Stats
Open	$4.36
Prev. Close	$4.37
EPS	-1.34
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$644.92M
PE Ratio	-

	LOW	HIGH
Day Range	4.36	4.37
52 Week Range	2.28	6.69

Ratios







EPS	-1.34

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies Corp (ADPT) is a biotechnology company that focuses on harnessing the power of the adaptive immune system to develop innovative diagnostics and therapeutics. The company utilizes its proprietary immune medicine platform to decode the immune system and its unique molecular biology in order to understand and diagnose diseases. With a deep understanding of the adaptive immune system, Adaptive Biotechnologies aims to transform medicine by enabling the development of personalized therapies based on an individual's immune profile.

The stock price history of Adaptive Biotechnologies Corp (ADPT) has shown significant fluctuations over the years. It has experienced both ups and downs, reflecting the volatile nature of the biotechnology industry. Investors should exercise caution and conduct thorough research before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A, M.B.A.
Headquarters: Seattle
Employees: 790
Exchange: NASDAQ

add Adaptive Biotechnologies to watchlist

Keep an eye on Adaptive Biotechnologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Adaptive Biotechnologies's (ADPT) price per share?

The current price per share for Adaptive Biotechnologies (ADPT) is $4.5. The stock has seen a price change of $0.13 recently, indicating a 2.97% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Adaptive Biotechnologies (ADPT)?

For Adaptive Biotechnologies (ADPT), the 52-week high is $6.7, which is 48.94% from the current price. The 52-week low is $2.28, the current price is 97.15% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Adaptive Biotechnologies (ADPT) a growth stock?

Adaptive Biotechnologies (ADPT) has shown an average price growth of -6.03% over the past three years. It has received a score of 10 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Adaptive Biotechnologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Adaptive Biotechnologies (ADPT) stock price performance year to date (YTD)?

As of the latest data, Adaptive Biotechnologies (ADPT) has a year-to-date price change of -5.77%. Over the past month, the stock has experienced a price change of -1.21%. Over the last three months, the change has been -2.49%. Over the past six months, the figure is 28.8%. Looking at a longer horizon, the five-year price change stands at -83.87%.

help

Is Adaptive Biotechnologies (ADPT) a profitable company?

Adaptive Biotechnologies (ADPT) has a net income of -$225.25M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 55.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -70.28% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $170.28M, although specific revenue growth data is currently not available. The gross profit is $94.72M. Operating income is noted at -$227.04M. Furthermore, the EBITDA is -$146.95M.

help

What is the market capitalization of Adaptive Biotechnologies (ADPT)?

Adaptive Biotechnologies (ADPT) has a market capitalization of $668.54M. The average daily trading volume is 4.43, indicating the stock's liquidity and investor engagement.

News

LABORATORY-DEVELOPED TESTS

LDTS

FDA REGULATIONS

CLINICAL LABORATORIES

DIAGNOSTIC SERVICES

DIAGNOSTIC PRODUCTS

Aug 15, 2024

Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024

HEMATOLOGIC MALIGNANCIES

DIAGNOSTIC TESTING

NEXT-GENERATION SEQUENCING

Hematologic Malignancies Testing Markets, 2023-2033: Growing Utilization of Next-Generation Sequencing and AI, Increasing Partnerships, Alliances, and Business Expansions among Key Players

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data - Zacks Investment Research

ARCUTIS BIOTHERAPEUTICS

Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why - Zacks Investment Research